Anti-Interleukin-12/23 Blockade Offers Novel Therapeutic Opportunities for the "Difficult" Patient with Crohn's Disease.


Philip S. Schoenfeld, Section Editor John Y. Kao, Section Editor 65 66 STAFF OF CONTRIBUTORS 67 68 69 70 71 72 73 74 75 Joseph Anderson, White River Junction, VT Johanna L. Chan, Houston, TX Matthew A. Ciorba, St. Louis, MO Massimo Colombo, Milan, Italy Gregory A. Cote, Charleston, SC Evan S. Dellon, Chapel Hill, NC Alex Ford, Leeds, United Kingdom Lauren B… (More)
DOI: 10.1053/j.gastro.2016.03.023


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.